Solid tumor other then cavity tumor
Conditions
Sponsors
Dongfang Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: All selected subjects must meet the following relevant conditions: 1. the patient or legal representative voluntarily participate, and signing the patient's informed consent form; 2. patients aged 18-80 years of age (subject to the date of signing the informed consent form); 3. patients with primary or secondary solid tumors (III-IV stage of lung cancer, hepatic carcinoma, renal cancer) who have been clinically diagnosed, and the lesions can be measured(The maximum diameter is 2-5 cm), requiring minimally invasive surgery; 4. no similar minimally invasive surgery was performed within 1 month; 5. those who have not undergone radiotherapy or chemotherapy within 2 month; 6. expected lifetime more than three months; 7. people who can correctly describe and are willing to participate in follow-up treatment; 8. patients who are considered suitable for this clinical study by the researcher.
Exclusion criteria
Exclusion criteria: If find one of the following relative conditions, the subject will not be able to participate in the clinical study: 1. There are traumatic injuries in the chest and abdomen that can cause surgical infection; 2. patients with severe infections and severe heart and brain diseases; have a history of immunodeficiency, including HIV testing positive (enzyme-linked immunosorbent assay and Western blotting); 3. Patients with previous severe pulmonary dysfunction, pulmonary ventilation disorder and multiple pulmonary bullae; 4. Patients with abnormal indexes in routine examination (blood routine, urine routine, liver and kidney function, ECG, biochemical test); 5. Patients with severe coagulation disorders; 6. Patients with recurrence or metastasis within 3 months after treatment with other methods; 7. pregnant or lactating women; 8.patient was taking part in other clinical trail; 9. patient did not signe the informed consent form; 10. patients who are considered unsuitable for this clinical study by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the iceball coverage efficiency;the overall of the response rate ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of treatment tolerance;The score of life quality; | — |
Countries
China
Contacts
Public ContactHu Kaiwen
Dongfang Hpspital Affiliated to Beijing University of Traditional Chinese Medicine
Outcome results
None listed